Post-treatment surveillance in colorectal cancer

Radiology and Oncology

Volumn 44, Issue 3, 2010, Pages 135-141

  Velenik, Vaneja ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

colorectal cancer; surveillance

Indexed keywords

OXALIPLATIN;

CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; FRACTURE; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; NEUROPATHY; PATIENT MONITORING; PRACTICE GUIDELINE; QUALITY OF LIFE; RECTOSCOPY; REVIEW; SEXUAL DYSFUNCTION; THORAX RADIOGRAPHY;

EID: 77958181103     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-010-0018-8     Document Type: Review

References (63)

1. Cancer incidence in Slovenia 2006. Report no. 48. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
2. Primic Žakelj M, Zadnik V, Žagar T, Zakotnik B. Survival of cancer patients, diagnosed in 1991-2005 in Slovenia. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
3. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Ann Intern Med 1998;129:27-35.
4. Velenik V. Locally recurrent rectal cancer: treatment options. Radiol Oncol 2009;43:144-51.
5. Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ, et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993;36:388-93.
6. Enblad P, Adami HO, Glimelius B, Krusemo U, Pahlman L. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer 1990;65:2091-100.
7. Bulow S, Svendsen LB, Mellemgaard A. Metachronous colorectal carcinoma. Br J Surg 1990;77:502-5.
8. Evans HS, Moller H, Robinson D, Lewis CM, Bell C M J, Hodgson SV. The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut 2001;50:647-52.
9. Shureiqi I, Coaksley CD, Morris J, Soliman AS, Levin B, Lippman SM: Effect of age on risk of second primary colorectal cancer. J Natl Cancer Inst 2001;93:1264-6.
10. Green RJ, Metlay JP, Propert K, Catalano PJ, Mayer RJ, Haller DG. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Int Med 2002;136:261-9.
11. Birgisson H, Plhlman L, Gunnarsson U, Glimelius B. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 2005;23:6126-31.
12. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998;129:27-35.
13. Anthony T, Fleming JB, Bieligk SC, Sarosi GA, Kim LT, Gregorcyk SG, et al. Postoperative colorectal cancer surveillance. J Am Coll Surg 2000;190:737-49.
14. Korner H, Soreide K, Stokkeland PJ, Soreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J GastrointestSur 2005;9:320-8.
15. Turk PS, Wanebo HJ. Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 1993;71(Suppl 12):4267-77.
16. Perše M, Cerar A. Physical activity and colorectal cancer. [Slovenian]. Zdrav Vestn 2009;78:399-405.
17. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995;130:1062-7.
18. Ohlsson B, Breland U, Ekberg H, Graffner H, Trannberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995;38:619-26.
19. Kjeldsen BJ, Kronborg O, Fenger C, Jřrgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997;84:666-9.
20. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998;114:7-14. (Pubitemid 28020948)
21. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 1998, 41:1127-33.
22. Secco GB, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G, et al. Efficacy and cost of risk-adapted follow up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002, 28:418-23.
23. Kovač V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer. Neoplasma 2004;51:334-40.
24. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intense follow-up after curative resection of colorectal cancer: systematic review and meta-analysis of randomized trials. Brit Med J 2002, 324:1-8.
25. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for n on-metastatic colorectal cancer. Cochrane Database Syst Rev 2002;1: CD002200.
26. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003;3:26.
27. Bruinvels DJ, Stiggelbout AM, Kievet J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer: A metaanalysis. Ann Surg 1994;219:174-82.
28. Rosen M, Chan L, Beart RW, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998;41:1116-26.
29. Grossmanna EM Johnsona FE, Virgoa KS, Longob WE, Fossatic R. Follow-up of colorectal cancer patients after resection with curative intent - The GILDA trial. Surg Oncol 2004;13:119-24.
30. Miklos M, Gajski G, Garaj-Vrhovac V. Usage of the standard and modified comet assay in assessment of DNA damage in human lymphocytes after exposure to ionizing radiation. Radiol Oncol 2009;43:97-107.
31. Kievit J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 2002;38:986-99.
32. Stiggelbout AM, de Haes JC, Vree R, van der Velde CJ, Brujninckx CM, van Groningen K, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997;75:914-20.
33. Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006;94:1116-21.
34. Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 1999;34:509-15.
35. Virgo KS, Vernava AM, Longo WE, McKirgan LW, Johnson FE. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 1995;273:1837-41.
36. Audisio RA, Setti-Carraro P, Segala M, Capko D, Andreoni B, Tiberio G. Follow-up in colorectal cancer patients: a cost-benefit analysis. Ann Surg Oncol 1996;3:349-57.
37. Zieren HU, Muller JM. After-care of gastrointestinal malignancies: an evaluation of costs and benefits. Zentralbl Chir 1996;121:167-76.
38. Rodríguez-Moranta F, Saló J, Arcusa A, Boadas J, Piñol V, Bessa X, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: A prospective, multicenter, randomized, controlled trial. J Clinl Oncol 2006;24:386-93.
39. Earle CC, Grunfeld E, Cripps MC, Stern HS. Cancer physicians' attitudes toward colorectal cancer follow-up. Ann Oncol 2003;14:400-5.
40. Haggstrom D, Arora N, Oakley-Girvan I. Primary and subspecialty care models of follow-up care delivery among colorectal cancer survivors [Abstract]. J Clin Oncol 2008;26(Suppl 1): Abstract 6540.
41. Snyder C, Earle C, Herbert R, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med 2008;23:254-9.
42. Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol 2008;26:1073-9.
43. Nissen MJ, Beran MS, Lee MW, Mehta SR, Pine DA, Swenson KK. Views of primary care physicians on follow-up care of cancer patients. Fam Med 2007;39:477-82.
44. Institute of Medicine. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academy Press; 2005.
45. Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006, 94:1116-21.
46. Ocvirk J. Advances in the treatment of metastatic colorectal carcinoma. Radiol Oncol 2009;43:1-8.
47. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance. 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005;23:8512-9.
48. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw 2009;7:838-81.
49. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw 2009;7:778-831.
50. Glimelius B, Oliveira J. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20(Suppl 4): iv54-6.
51. Van Cutsem EJ, Oliveira J. Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2009;20(Suppl 4): iv49-50.
52. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701.
53. Collette L, Bosset JF, den Dulk M, Nguyen F, Mineur L, Maingon P, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the Europea. J Clin Oncol 2007;25:4379-86.
54. Van Cutsem E, Dicato M, Haustermans K, Arber N, Bosset JF, Cunningham D, et al. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from 9th World Congress on Gastrointestinal Cancer, Barcelona 2007. Ann Oncol 2008;19(Suppl 6): vi1-8.
55. Velenik V, Oblak I, Anderluh F. Quality of life in patients after combined modality treatment of rectal cancer: Report of a prospective phase II study. Radiol Oncol 2008;42:207-14.
56. Schneider EC, Malin JL, Kahn KL, Ko CY, Adams J, Epstein AM. Surviving colorectal cancer: patient-reported symptoms 4 years after diagnosis. Cancer 2007;110:2075-82.
57. Sprangers M A G, Taal BG, Aaronson NK, Velde A. Quality of life in colorectal cancer: stoma vs.nonstoma patients. Dis Colon Rectum 1995;38:361-9.
58. Kalso E, Tasmuth T, Neuvanen PJ. Amitriptyline effectively relieves neuropatic pain following treatment of breast cancer. Pain 1996;64:293-302.
59. Baxter NN, Habermann EB, Tepper JE, Durham SB, Virnig BA. Risk of pelvic fractures in older women following pelvic irradiation. JAMA 2005;294:2587-93.
60. Vernava AM 3rd, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1994;37:573-83.
61. Giordano P, Efron J, Vernava AM III, Weiss EG, Nogueras JJ, Wexner SD. Strategies of follow-up for colorectal cancer: a survey of the American Society of Colon and Rectal Surgeons. Tech Coloproctol 2006;10:199-207.
62. Rolnick S, Hensley Alfors S, Kucera GP, Fortman K, Ulcickas Yood M, Jankowski M, et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Caner Inst Monogr 2005;96-101.
63. Cooper GS, Kou DT, Reynolds HL Jr. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis. Cancer 2008;113:2029-37.